ANI Pharmaceuticals Inc (ANIP) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.79x

ANI Pharmaceuticals Inc (ANIP) has a Cash Flow Reinvestment Rate of 0.79x as of December 2025, reinvesting $23.86 Million (capex $23.86 Million ) from operating cash flow of $30.37 Million. Explore ANIP capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.79x
(Capex + Investments) / Operating CF

Total Reinvested

$23.86 Million
Capex + Investments

Operating Cash Flow

$30.37 Million
USD

Capital Expenditures

$23.86 Million
USD

ANI Pharmaceuticals Inc Cash Flow Reinvestment Rate (2007–2025)

Historical reinvestment intensity for ANI Pharmaceuticals Inc across 12 annual periods. Also explore ANIP asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for ANI Pharmaceuticals Inc (2007–2025)

Year-by-year capital reinvestment analysis for ANI Pharmaceuticals Inc. For live market cap and broader valuation context, see ANIP market cap.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.07x $13.84 Million $185.22 Million $13.84 Million ▼ -98.9%
2024 6.59x $421.67 Million $64.02 Million $16.95 Million ▲ +2114.4%
2023 0.30x $35.38 Million $118.96 Million $18.51 Million ▼ -99.2%
2021 38.87x $129.12 Million $3.32 Million $23.64 Million ▲ +334.3%
2020 8.95x $136.64 Million $15.27 Million $68.32 Million ▲ +641.2%
2019 1.21x $55.10 Million $45.63 Million $27.55 Million ▲ +111.5%
2018 0.57x $38.29 Million $67.07 Million $10.91 Million ▼ -89.6%
2017 5.48x $215.99 Million $39.42 Million $107.99 Million ▼ -50.3%
2016 11.03x $303.12 Million $27.47 Million $149.06 Million ▲ +482.8%
2015 1.89x $32.68 Million $17.26 Million $32.68 Million ▲ +16.7%
2014 1.62x $35.75 Million $22.03 Million $35.75 Million ▲ +3980.5%
2007 0.04x $29.43K $739.99K $29.43K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow